Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAMIC: Ramipril for COVID-19
NCT04366050Phase 2Completed
- Sponsor
- University of California, San Diego
- Start
- May 2020
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ramipril in coronavirus disease 2019 (COVID-19), sponsored by University of California, San Diego. Started May 2020; status: completed.
02
Drugs
ramipril
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04366050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04366050.